Main Menu

Researchers and Groups

Researchers Groups

Research division

Research group

Researcher name

Group Leaders

Professor Judith Bliss

Dr Maggie Cheang

Professor Louis Chesler

Professor Ceire Costelloe

Professor Johann De Bono

Dr Sally George

Professor Emma Hall

Dr Adam Sharp

Professor Christina Yap

Senior Researchers

Dr Chiara Gorrini

 Jo Haviland

Dr Nuria Porta

Honorary Faculty

Professor Susana Banerjee

Dr Julia Chisholm

Professor Robin Jones

Professor James Larkin

Dr Henry Mandeville

 Dr Lynley Marshall

Professor Sanjay Popat

Professor Samra Turajlic

Associate Honorary Faculty

Dr Fernando Carceller

Thomas Ind

Research division

Group name

Acute Leukaemia

Group leader: Dr David Taussig

Biology of Childhood Leukaemia

Group leader: Sir Mel Greaves

Breast Cancer Clinical Research

Group leader: Dr Alistair Ring

Breast Cancer Collaborations

Group leader: Professor Andrew Tutt

Breast Cancer Immunology

Group leader: Professor Alan Melcher

Breast Cancer Radiotherapy

Group leader: Dr Anna Kirby

Breast Cancer Research Bioinformatics Group

Breast Cancer Systemic Therapy Trials

Group leader: Dr Alicia Okines

Breast Epigenetic Plasticity and Evolution

Group leader: Professor Luca Magnani

Breast Surgery Outcome Measures

Group leader: Jennifer Rusby

Cancer and Genome Instability

Group leader: Professor Wojciech Niedzwiedz

Cancer Biomarkers

Group leader: Professor Johann De Bono

Cancer Dynamics

Group leader: Dr Stephen-John Sammut

Cancer Genomics

Group leader: Professor Richard Houlston

Cancer Stem Cell

Group leader: Professor Axel Behrens

Cell Death and Immunity

Group leader: Professor Pascal Meier

Cell Division

Group leader: Professor Jonathon Pines

Chromatin Biology

Group leader: Dr Alex Radzisheuskaya

Chromosomal Translocations and Intracellular Antibody Therapeutics

Group leader: Professor Terence Rabbitts

Chronic Lymphoid Malignancies: Clinical Trials and Translational Research (El-Sharkawi)

Group leader: Dr Dima El-Sharkawi

Clinical Academic Radiotherapy (Huddart)

Group leader: Professor Robert Huddart

Clinical Cancer Epidemiology

Group leader: Professor Amy Berrington

Clinical Pharmacodynamics Biomarker Group

Group leader: Professor Udai Banerji

Clinical Pharmacology & Trials (including Drug Metabolism and Pharmacokinetics Group)

Group leader: Professor Udai Banerji

Clinical Pharmacology Adaptive Therapy Group

Group leader: Professor Udai Banerji

Computational Biology and Chemogenomics

Group leader: Dr Gary Newton

Computational Imaging

Group leader: Dr Matthew Blackledge

Computational Pathology and Integrative Genomics

Group leader: Professor Janet Shipley

Cytoskeleton and Cancer Metastasis

Group leader: Professor Victoria Sanz-Moreno

Development and Cancer

Group leader: Dr Amanda Swain

Developmental Oncology

Group leader: Dr Sally George

Drug Target Discovery

Group leader: Professor Andrew Tutt

Dynamical Cell Systems

Group leader: Professor Chris Bakal

Endocrine Control Mechanisms

Group leader: Professor Cathrin Brisken

Endocrine Therapy Resistance

Group leader: Professor Stephen Johnston

Epigenetics and Cancer

Group leader: Professor Kristian Helin

Epigenetics and Genome Stability

Group leader: Professor Jessica Downs

Evolutionary Genomics and Modelling

Group leader: Professor Andrea Sottoriva

Evolutionary Immunogenomics

Group leader: Dr Luis Zapata Ortiz

Functional Genetic Epidemiology

Group leader: Professor Olivia Fletcher

Functional Genomics

Group leader: Dr Rachael Natrajan

Functional Imaging

Group leader: Professor Christina Messiou

Functional Proteomics

Group leader: Professor Jyoti Choudhary

Functional Tumour Immunology

Group leader: Dr Esther Arwert

Gastrointestinal Clinical Oncology

Group leader: Dr Diana Tait

Gene Function

Group leader: Professor Chris Lord

Genome Replication

Group leader: Dr Gideon Coster

Genome Stability and Innate Immunity

Group leader: Dr Christian Zierhut

Genomics and Evolutionary Dynamics

Group leader: Professor Trevor Graham

Glioma

Group leader: Professor Chris Jones

Gynaecological Cancers (Systemic Therapy and Clinical Trials)

Group leader: Professor Susana Banerjee

Gynaecological Oncology Surgery

Group leader: Thomas Ind

Haemato-Oncology

Group leader: Professor Kamil Kranc

Health Informatics

Group leader: Professor Ceire Costelloe

Hit Discovery and Structural Design

Group leader: Dr Rob Van Montfort

ICR-CTSU Breast and Rare Cancers Trials

Group leader: Professor Judith Bliss

ICR-CTSU Early Phase and Adaptive Trials

Group leader: Professor Christina Yap

ICR-CTSU Integrative Genomic Analysis in Clinical Trials

Group leader: Dr Maggie Cheang

ICR-CTSU Radiotherapy, Urology and Head and Neck Cancers Trials

Group leader: Professor Emma Hall

Imaging for Radiotherapy Adaptation

Group leader: Dr Emma Harris

Integrated Pathology

Group leader: Professor Manuel Salto-Tellez

Integrative Cancer Epidemiology

Group leader: Professor Montse Garcia-Closas

Lymphoma biology and imaging

Group leader: Dr Sunil Iyengar

Macromolecular Structural Biology

Group leader: Professor Laurence Pearl

Magnetic Resonance

Group leader: Professor Kevin Harrington

Magnetic Resonance Imaging in Radiotherapy

Group leader: Dr Andreas Wetscherek

Mechanisms and Regulation of pre-mRNA Splicing

Group leader: Professor Vlad Pena

Medicinal Chemistry 1

Group leader: Dr Gurdip Bhalay

Medicinal Chemistry 3

Group leader: Dr Gary Newton

Medicinal Chemistry 4 (including Analytical Chemistry)

Group leader: Professor Swen Hoelder

Melanoma and Kidney Cancer

Team leaders: Professor James Larkin
Professor Samra Turajlic

Molecular and Systems Oncology

Group leader: Dr Paul Huang

Molecular Cell Biology

Group leader: Professor Clare Isacke

Molecular Mechanisms of Cell Cycle Regulation

Group leader: Dr Claudio Alfieri

Molecular Oncology

Group leader: Professor Nick Turner

Multimodality Molecular Imaging

Group leader: Dr Dimitra Darambara

Myeloma Biology and Therapeutics

Group leader: Dr Charlotte Pawlyn

Myeloma Group

Group leader: Professor Richard Houlston

Myeloma Molecular Therapy

Group leader: Dr Martin Kaiser

Oncogenetics

Group leader: Professor Rosalind Eeles

Paediatric & Adolescent Neuro-Oncology and Drug Development (Carceller)

Group leader: Dr Fernando Carceller

Paediatric Solid Tumour Biology and Therapeutics

Group leader: Professor Louis Chesler

Post-translational Modifications and Cell Proliferation

Group leader: Dr Joerg Mansfeld

Preclinical Modelling of Paediatric Cancer Evolution

Group leader: Dr Alejandra Bruna

Preclinical Molecular Imaging

Group leader: Dr Gabriela Kramer-Marek

Pre-Clinical MRI

Group leader: Professor Simon Robinson

Prostate and Bladder Cancer Research

Group leader: Professor Nick James

Prostate Cancer Targeted Therapy Group

Group leader: Professor Johann De Bono

Quantitative Biomedical Imaging

Group leader: Professor James O'Connor

Radiation-enhanced Immunotherapy

Group leader: Dr Erik Wennerberg

Radioisotope Physics

Group leader: Dr Glenn Flux

Radiotherapy Physics Modelling

Group leader: Professor Uwe Oelfke

RNA Biology and Molecular Therapeutics

Group leader: Dr Paul Clarke

Sarcoma and Melanoma Surgery

Group leader: Professor Andrew Hayes

Sarcoma Clinical Trials (R Jones)

Group leader: Professor Robin Jones

Sarcoma Clinical Trials in Children and Young People

Group leader: Dr Julia Chisholm

Sarcoma Molecular Pathology

Group leader: Professor Janet Shipley

Short Linear Motif

Group leader: Dr Norman Davey

Signal Transduction and Molecular Pharmacology

Group leader: Professor Paul Workman

Signalling & Cancer Metabolism

Group leader: Dr George Poulogiannis

Stereotactic and Precision Radiotherapy

Group leader: Professor Nicholas van As

Structural Biology of Cell Signalling

Group leader: Professor Sebastian Guettler

Structural Biology of DNA Repair Complexes

Group leader: Dr Basil Greber

Systems and Precision Cancer Medicine

Group leader: Dr Anguraj Sadanandam

Target Biology and Genomic Instability

Group leader: Dr Olivia Rossanese

Target Evaluation and Molecular Therapeutics

Group leader: Dr Olivia Rossanese

Target Validation and DNA Damage Response

Group leader: Professor Andrew Tutt

Targeted Therapy

Group leader: Professor Kevin Harrington

Telomere Biology

Group leader: Dr Max Douglas

The Adult Drug Development Unit at the ICR and the RM

Group leader: Professor Johann De Bono

Therapeutic Ultrasound

Group leader: Professor Gail Ter Haar

Thoracic Oncology

Group leader: Professor Sanjay Popat

Thoracic Oncology Immunotherapy Group

Group leader: Dr Astero Klampatsa

Translational Breast Radiobiology

Group leader: Dr Navita Somaiah

Translational Genetics

Group leader: Professor Clare Turnbull

Translational Immunotherapy

Group leader: Professor Alan Melcher

Translational Sarcoma, Melanoma and Rare Tumour Surgery

Group leader: Myles Smith

Translational Therapeutic Radiography

Group leader: Professor Helen McNair

Translational Therapeutics

Group leader: Dr Adam Sharp

Tumour Functional Heterogeneity

Group leader: Dr Marco Bezzi

Tumour Microenvironment and Pharmacology

Group leader: Dr Ling Li

Ultrasound and Optical Imaging

Group leader: Professor Jeff Bamber

Uro-oncology Clinical Trials

Group leader: Dr Alison Tree

Vannini Group

Group leader: Professor Laurence Pearl

View all teams